---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-219365"
form_type: "8-K"
ticker: "GUTS"
cik: "0001572616"
company_name: "FRACTYL HEALTH, INC."
filed_at: "2026-05-12T20:05:16+00:00"
generated_at: "2026-05-12T21:36:23.138315+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Fractyl Health Q1 net income $9.2M on non-cash warrant change; Revita pivotal data on track for early Q4

## Summary
- Q1 R&D expenses $15.6M (down from $19.4M YoY); SG&A $5.2M; adjusted EBITDA -$18.0M.
- Cash $63.2M; runway into early 2027, beyond anticipated pivotal data readout.
- Revita REMAIN-1 Pivotal topline 6-month data expected early Q4 2026; FDA De Novo submission target late Q4 2026.
- 1-year REVEAL-1 Cohort data in Q2 2026; 1-year randomized REMAIN-1 Midpoint data in Q3 2026.
- RJVA-001 first-in-human dosing and preliminary data expected in H2 2026 after Netherlands CTA authorization.

## SEC filing metadata
- accession: 0001193125-26-219365
- form_type: 8-K
- ticker: GUTS
- cik: 0001572616
- company_name: FRACTYL HEALTH, INC.
- filed_at: 2026-05-12T20:05:16+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1572616/000119312526219365/0001193125-26-219365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1572616/000119312526219365/guts-20260512.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-219365
- JSON: https://secwatch.observer/filing/0001193125-26-219365.json
- Plain text: https://secwatch.observer/filing/0001193125-26-219365.txt

## Key facts
- Earnings Releases
  FRACTYL HEALTH, INC. reported the quarter ended March 31, 2026 results: net income $9.2 million. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2026
  - Net income: $9.2 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Fractyl Health, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1572616/000119312526219365/0001193125-26-219365-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.